Magnetar Financial’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,555
Closed -$141K 1365
2025
Q4
$141K Buy
+13,555
New +$136K ﹤0.01% 829
2023
Q2
Sell
-88,236
Closed -$1.47M 595
2023
Q1
$1.47M Sell
88,236
-81,905
-48% -$1.16M 0.03% 336
2022
Q4
$2.16M Buy
170,141
+50,820
+43% +$618K 0.04% 394
2022
Q3
$1.43M Sell
119,321
-7,652
-6% -$105K 0.02% 652
2022
Q2
$1.79K Sell
126,973
-132,585
-51% -$1.75M 0.02% 751
2022
Q1
$3.21M Buy
259,558
+5,421
+2% +$65.1K 0.03% 536
2021
Q4
$2.86M Sell
254,137
-27,277
-10% -$328K 0.03% 592
2021
Q3
$3.57M Buy
+281,414
New +$3.87M 0.04% 472

Other funds holding RXST

Magnetar Financial's RXST Position: Q1 2026 in Review

Magnetar Financial sold out of RxSight (RXST) in Q1 2026, closing a stake of 13,555 shares — an estimated $141K sold.

Magnetar Financial first reported a position in RXST in Q3 2021 and held it in 8 quarters. The position peaked at $3.57M in Q3 2021. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Magnetar Financial reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
  • Magnetar Financial sold 13,555 RxSight shares in Q1 2026, an estimated $141K.
  • Magnetar Financial first reported a position in RxSight in Q3 2021 and held it in 8 quarters.
  • Magnetar Financial's RxSight position peaked at $3.57M in Q3 2021.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.